Skip to main content
. 2022 Mar 24;14:17588359221085232. doi: 10.1177/17588359221085232

Figure 4.

Figure 4.

Anti-tumor activity of pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer patients with brain metastases.